[1] ElSerag H B, Rudolph K L. Hepatocellular carcinoma:Epidemiology and molecular carcinogenesis[J]. Gastroenterology, 2007,132(7):2557-2576.
[2] Johnson P J, Qin S K, Park J W, et al. Brivanib versus sorafenib as firstline therapy in patients with unresectable, advanced hepatocellular carcinoma: Results from the randomized phase III BRISKFL study[J]. Journal of Clinical Oncology, 2013,31(28):3517-3524.
[3] Su T S, Lu H Z, Cheng T, et al. Longterm survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5cm[J]. BMC Cancer, 2016,16(1):1-9.
[4] Lee C, Longo V D. Fasting vs dietary restriction in cellular protection and cancer treatment: From model organisms to patients[J]. Oncogene, 2011,30(30):3305-3316.
[5] Patterson R E, Sears D D. Metabolic effects of intermittent fasting[J]. Annual Review of Nutrition, 2016, 37(1):371-393.
[6] Brandhorst S, Longo VD. Fasting and caloricrestriction in cancer prevention and treatment[J]. Recent Results Cancer Res, 2016,207:241-266.
[7] Fernando S, Sebastian B, Min W, et al. Fasting enhances the response of glioma to chemo and radiotherapy[J]. Plos One, 2012,7(9):1-9.
[8] Pazienza V, Vinciguerra M, D’Aronzo M, et al. Fasting cycles potentiates the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models[J]. Oncotarget, 2015,6(21):18545-18557.
[9] Thomas J A, Poulton S H, Phillips T E, et al. Effect of intermittent fasting on prostate cancer tumor growth in a mouse model[J]. Journal of Urology, 2010,181(4):350-355.
[10] Lankelma J, Kooi B, Krab K, et al. A reason for intermittent fasting to suppress the awakening of dormant breast tumors[J]. Biosystems, 2015,127:1-6.
[1]周驰凯,潘强.6种化合物对肝癌细胞活性影响的比较[J].浙江理工大学学报,2015,33-34(自科2):249.
ZHOU Chi kai,PAN Qiang.Comparison of Effects of Six Chemical Compounds on Activity of Liver Cancer Cell[J].Journal of Zhejiang Sci-Tech University,2015,33-34(自科六):249.
[2]孙笑竹,吕春伟,秦云,等.CDK抑制剂SNS 032联合AD55 Apoptin对肝癌细胞Huh 7的体外抗癌作用[J].浙江理工大学学报,2016,35-36(自科2):290.
SUN Xiaozhu,L Chunwei,QIN Yun,et al.In vitro Antitumor Effect of Combining CDK Inhibitor SNS 032 with AD55 Apoptin on Liver Carcinoma Cell Huh[J].Journal of Zhejiang Sci-Tech University,2016,35-36(自科六):290.
[3]郑娓诗,孙艺钦,赵雪芹,等.纳米明胶硅氧烷的制备及其负载p-53基因对肝癌抑制效果[J].浙江理工大学学报,2018,39-40(自科5):605.
ZHENG Weishi,SUN Yiqin,ZHAO Xueqin,et al.Preparation of nanogelatin siloxane and inhibition effect of its loaded p53gene on the hepatocellular carcinoma[J].Journal of Zhejiang Sci-Tech University,2018,39-40(自科六):605.
[4]杜春明,刘新垣.双基因溶瘤腺病毒OAd-mK5-shPKM2抗肝癌活性的初步探究[J].浙江理工大学学报,2019,41-42(自科一):106.
DU Chunming,LIU Xinyuan.Antitumor effect of oncolytic adenovirus armed with mK5 and shPKM2 in liver cancer[J].Journal of Zhejiang Sci-Tech University,2019,41-42(自科六):106.